NCT05725824

Brief Summary

Normal hearing participants will be fit with a hearing aid and different types of customized earmolds. Hearing aids will be programmed to a simulated mild, flat, sensorineural hearing loss of 30 dB HL from 250-8000Hz. Objective acoustic real ear measures and subjective ratings of sound quality and physical comfort will be evaluated and compared between earmolds. Findings will help researchers to better understand the impacts of different earmolds and how each might affect overall point-of-care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 3, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 13, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

July 30, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 17, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 17, 2024

Completed
6 months until next milestone

Results Posted

Study results publicly available

July 29, 2024

Completed
Last Updated

July 29, 2024

Status Verified

July 1, 2024

Enrollment Period

6 months

First QC Date

February 3, 2023

Results QC Date

May 7, 2024

Last Update Submit

July 25, 2024

Conditions

Keywords

earmoldhearing aid

Outcome Measures

Primary Outcomes (4)

  • Real Ear Measures

    Evaluation of ear canal acoustics with participant wearing a hearing aid and earmold type (3d party control, in-house\_Resin, in-house\_PLA). Then, a thin microphone tube is placed in the ear canal to measure the average amount gain (dB SPL) across various frequencies (250-8000Hz) while the participant sits in front of a speaker playing sound samples. Results are recorded in gain (dB SPL) across frequencies. Once complete, the earmold type is changed and recording is repeated until all ear mold material types have been tested for each individual. Arms/Groups were collapsed for RM-ANOVA to compare between various earmold types. A post-hoc paired t-test w/ Bonferroni correction was utilized to compare ear mold material types.

    15 minutes

  • Outer Effectiveness of Auditory Rehabilitation (EAR) Questionnaire

    A questionnaire eliciting patient perception of physical comfort, quality of voice, and overall self-perceived satisfaction. Includes 12 items (5 point) that are scored on a 0 to 100, with 100 representing best possible function/rating

    2nd listening session appointment (15 minutes)

  • Physical Dimensions

    Physical dimensions of each ear mold type (3rd party Control, in-house\_Resin, in-house\_PLA) were taken using digital calipers in millimeters prior to being worn by participants.

    Prior to 2nd listening session appointment (15 minutes)

  • Production Variable

    The total raw cost ($) for each ear mold type (3rd party\_control, in-house\_RES, and in-house\_PLA).

    Prior to 2nd listening session appointment (15 minutes)

Study Arms (3)

Third-party control

ACTIVE COMPARATOR

Ear canal impressions will be will be packaged and sent to a professional third-party manufacturer for fabrication in an acrylic material-type. These will serve as the control earmolds, by which the in-house study/intervention earmolds will be compared against. To control for style of earmolds, all earmolds will be made in a skeleton style with a sound bore that accommodates size #13 tubing and a separate select-a-vent (SAV).

Device: BTE hearing aid with compatible earmolds

In-house Study group_Resin

EXPERIMENTAL

Custom earmold impressions will be scanned and edited using computer-aided design software. These 3D earmold meshes will then be converted to g-code using licensed software and sent to a stereolithography 3D printer for fabrication. Participants will only wear these study earmolds for the duration of testing.To control for style of earmolds, all earmolds will be made in a skeleton style with a sound bore that accommodates size #13 tubing and a separate select-a-vent (SAV).

Device: BTE hearing aid with compatible earmolds

In-house Study group_PLA

EXPERIMENTAL

Custom earmold impressions will be scanned and edited using computer-aided design software. These 3D earmold meshes will then be converted to g-code using licensed software and sent to a fused deposition modeling 3D printer for fabrication. Participants will only wear these study earmolds for the duration of testing. To control for style of earmolds, all earmolds will be made in a skeleton style with a sound bore that accommodates size #13 tubing and a separate select-a-vent (SAV).

Device: BTE hearing aid with compatible earmolds

Interventions

Hearing aids will be fit with three different types of customized earmolds. They will only wear each earmold group for the duration of the test (total = \~2.5 hours). Hearing aids will be programmed to a simulated mild, flat, sensorineural hearing loss of 30 dB HL from 250-8000Hz. A short washout period will follow completion of testing with ear earmold group.

In-house Study group_PLAIn-house Study group_ResinThird-party control

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Normal hearing thresholds (\<25 dB HL) at octave frequencies from 250-8000Hz.
  • Normal otoscopy: patent ear canals with normal appearing eardrums and aerated middle ear, bilaterally.
  • English as primary spoken language.

You may not qualify if:

  • history of extensive or current outer or middle ear pathology.
  • history of extensive outer or middle ear surgery.
  • history of neurological or cognitive disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arizona

Tucson, Arizona, 85721, United States

Location

Results Point of Contact

Title
Dr. Bryan Wong
Organization
University of Arizona

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 3, 2023

First Posted

February 13, 2023

Study Start

July 30, 2023

Primary Completion

January 17, 2024

Study Completion

January 17, 2024

Last Updated

July 29, 2024

Results First Posted

July 29, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations